CPHI Milan Wrap-Up Report: Conference Highlights

Discover the emerging and trending topics of the pharmaceutical industry with our CPHI Milan Conference Highlights, with exclusive insight from pharmaceutical leaders and experts! 

The Future of Pharma Manufacturing 

President of Medicines for Europe Elisabeth Stampa gave her opening remarks at the Manufacturing 5.0 theatre on day 1 of CPHI Milan, addressing the colossal topic of the future of pharmaceutical manufacturing. With a broad but concise overview of the key manufacturing trends, Stampa listed several major developments in pharmaceutical manufacturing 5.0, including AI and automation of manufacturing, continuing sustainability and Green Chemistry efforts, and regulatory harmonisation of manufacturing practices. “Different regulators around the world must agree on what they accept or don’t accept, what the industry proposes to national health authorities, and how they harmonise and understand each other, which isn’t easy,” Stampa stated. 

Pharma Manufacturing in Emerging Markets – Towards Localisation in Africa? 

The panel discussion on Pharma Manufacturing in Emerging Markets – Towards Localisation in Africa? also contended with the future of pharmaceutical manufacturing in regional and emerging markets, particularly in the African region. Moderated by Pushpa Vijayaraghavan, Director & Practice Lead – Healthcare at Sathguru, important insights were brought up regarding access to capital for fundable projects, as well as talent development in pharmaceutical manufacturing across the African region. Partnerships was a buzzword during the panel – it will be important for all to work together to build the basics like talent, capital, and create enablers to attract companies to set-up and run successful businesses within the African continental hub. 

Why the Middle East can be the New Frontier for Next Generation Medicine 

This panel looked at the largest market in the Middle East, and why it is set to become the next frontier for biotechnology. Detailing the aspirations of the National Biotechnology Strategy, the speakers covered each aspect of the strategy and how the whole region is working towards the goals of Vision 2030. Main disease focus areas mentioned by the panel include anti-diabetes medicines, followed by oncology and immunology. Future disease areas of focus are growing thanks to further research and investment in areas like genomics. This is further encouraged with the influx of talent from different areas bringing new perspective and ideas to the biotech field in the Middle East. The new infrastructure in the region and the investment into research genomics set up the Middle East for being able to produce more medications and hopefully solve several health problems. 

For more conference highlights from CPHI Milan, download the CPHI Milan Wrap-Up Report.